Target Name: LOC105374316
NCBI ID: G105374316
Review Report on LOC105374316 Target / Biomarker Content of Review Report on LOC105374316 Target / Biomarker
LOC105374316
Other Name(s): LOC105374316 variant X2 | Uncharacterized LOC105374316, transcript variant X2

Unlocking the Potential of LOC105374316: A Variant of interest for Drug Targets and Biomarkers

Introduction

LOC105374316 is a unique gene variant that has attracted widespread attention from scientists and medical researchers. This variant site is located on the human chromosome and belongs to the non-coding RNA (ncRNA) family. ncRNA plays an important role in the regulation of gene expression and can affect a variety of biological processes. The study found that the LOC105374316 mutation site may be a potential drug target or biomarker. This article will elaborate on the characteristics of the LOC105374316 variant site and its potential value in drug research and clinical application.

Characteristics of the LOC105374316 mutation site

The LOC105374316 mutation site is located in a family of non-coding RNAs on human chromosomes. This family includes multiple genes, the most important of which is LOC105374316. LOC105374316 is an RNA molecule composed of a DNA sequence and is approximately 290 nucleotides in length. The study found that the length and sequence diversity of the LOC105374316 variant site play an important role in the regulation of gene expression.

There are multiple variants of known genes near the LOC105374316 mutation site. These variants may interact with LOC105374316 to jointly regulate gene expression. The study found that the combination of these variants with LOC105374316 results in differences in transcripts, thereby affecting gene expression. In addition, the researchers also found that the expression level of the variant at the LOC105374316 mutation site is different from that of the normal gene, which provides clues for studying its function.

The potential value of LOC105374316 in drug research and clinical applications

The LOC105374316 mutation site has broad application prospects in drug research and clinical applications. First, as a drug target, the LOC105374316 variant site may be a potential drug target that can be used to treat a variety of diseases. For example, studies have found that the LOC105374316 variant is positively correlated with the expression levels of certain cancer-related genes. Therefore, studying the LOC105374316 mutation site may provide new targets for cancer treatment.

Secondly, the LOC105374316 mutation site can also be used as a biomarker for disease diagnosis and prognosis. Biomarkers refer to molecular or cellular changes that can be used for disease diagnosis and prognosis. The study found that the LOC105374316 variant has differences in gene expression levels related to certain diseases. Therefore, using the LOC105374316 variant as a biomarker can provide a new basis for disease diagnosis and prognosis.

in conclusion

LOC105374316 is a mutation site with broad application prospects. By studying the characteristics of the LOC105374316 variant site, its potential value in drug research and clinical application can be revealed. Future research will continue to deeply explore the mechanism of action of the LOC105374316 variant site, bringing new hope to human health.

Protein Name: Uncharacterized LOC105374316, Transcript Variant X2

The "LOC105374316 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374316 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170